4//SEC Filing
MACFARLANE M DAVID 4
Accession 0001104659-22-001621
CIK 0000910267other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 6:53 PM ET
Size
5.2 KB
Accession
0001104659-22-001621
Insider Transaction Report
Form 4
TITAN PHARMACEUTICALS INCTTNP.OB
MACFARLANE M DAVID
Director
Transactions
- Award
Option to Purchase Common Stock
2022-01-05+10,000→ 10,000 totalExercise: $1.18From: 2022-07-05Exp: 2032-01-05→ Common Stock (10,000 underlying)
Documents
Issuer
TITAN PHARMACEUTICALS INC
CIK 0000910267
Entity typeother
Related Parties
1- filerCIK 0001182314
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 6:53 PM ET
- Size
- 5.2 KB